Navigation Links
DrugDev to Promote Adoption of Innovative Technologies to Advance Clinical Study Efficiency at Prestigious Pharma and Biotech Industry Conferences in Q4
Date:9/21/2017

Executives and subject matter experts from DrugDev, a QuintilesIMS company, who enable the world’s most progressive pharma and biotech organizations to do more clinical trials will share best practices learned from over 2,000 clinical trials at top pharma and biotech events in Q4.

DrugDev will demonstrate DrugDev Spark™, the world’s first unified clinical operations suite which improves global trials from planning through closeout, with proven solutions including site selection and feasibility (featuring the DrugDev Golden Number universal identifier), site activation, eConsent, site payments, LMS, site engagement, document management and more.

2017 Global Site Solutions Summit | October 5-8, Boca Raton – October 5-8, Boca Raton – Summit faculty member Melissa “Liss” Easy, DrugDev founder and President, SiteStart will apply her passion for improving the site-patient relationship by judging entrants for the SCRS Site Patient Recruitment Innovation Award. Presentations will take place October 7, and the winner will be announced October 8. Liss also will participate in a panel discussion, “Stand Out in Site Identification,” on October 7, 3:00-4:00 pm. Liss founded DrugDev to bring sponsors, sites and patients together through better technology-driven solutions and services, and more open communication. Her honors include being named to the PharmaVOICE 100 and winning the Partnerships in Clinical Trials Woman of the Year award. And, see a demonstration of DrugDev Spark at Booth 406.

2017 Society of Clinical Research Associates (SOCRA), | October 6-8, Orlando – Dr. Susan Brink, eConsent visionary and DrugDev Strategic Advisor, Patient Solutions will present “Considerations When Implementing e-Consent.” Investigative sites are the linchpins in the adoption of eConsent. Dr. Brink’s presentation, part of the “Data Management / EDC” track, takes place October 6, 4:15-5:00 pm. Attendees will learn about:

  • FDA guidelines for eConsent and components that address the guidelines
  • Elements of eConsent which investigators report are especially helpful, including version tracking, electronic handwritten signatures, and availability on a tablet device
  • The importance of site preparation and attention to the needs of the site staff
  • Lessons learned through implementation of eConsent at clinical sites for over 100 trials. Specific examples of actions that can be taken to aid sites during initial stages of adoption will be shared

Clinical operations executives may also connect with DrugDev at additional meetings:

To schedule a demo of DrugDev Spark – the world’s first unified clinical operations suite – email solutions(at)drugdev(dot)com.

About DrugDev
DrugDev, a QuintilesIMS company, helps the world do more trials through industry-wide collaboration, standardization and a beautiful technology experience. DrugDev Spark™, the unified clinical operations suite, is comprised of proven solutions used by 85 sponsors and CROs on over 2,000 clinical trials to transform the quality and efficiency of clinical trials from startup through closeout. DrugDev Spark is powered by the DrugDev Golden Number, the award-winning universal identifier for global site facilities and investigators used by TransCelerate and the Investigator Databank. Learn why 9 of the top 10 sponsors and 4 of the top 5 CROs trust DrugDev by scheduling a demo of DrugDev Spark at drugdev.com.

Read the full story at http://www.prweb.com/releases/2017/09/prweb14718999.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Pharma, Biotech Clinical Trial Leaders to Convene for 3rd Annual DrugDev Summit to Promote Collaboration, Technology Innovation, Engaged Sites, and More Informed Patients
2. Demand for DrugDev Spark™ Soars Among Small Biotechs and Pharma Seeking Best-in-Class Technology for Clinical Trial Planning, Startup and Conduct
3. DrugDev and SCRS Present Educational Webinar on How to Develop an Efficient and Compliant Clinical Trial Start-Up Process
4. DrugDev Teams with CISCRP and SCRS to Present Educational Webinars Highlighting the Patient-Friendly Benefits of eConsent
5. DrugDev Joins Boston’s Technology Trendsetters to Host MassTLC’s NewCo Festival in Boston
6. DrugDev Hosts New Educational Webinar on Overcoming the Challenges of Rare Disease Clinical Trials
7. Connect with DrugDev at the SCOPE Summit for Clinical Operations Executives for Engaging Customer-Led Panel Discussions and the Anticipated Reveal of DrugDev Spark™
8. 100 Clinical Trial Leaders Convene for the 2nd Annual DrugDev User Summit (Hosted by Merck) to Promote Industry Collaboration, Technology Innovation and Site Satisfaction
9. DrugDev Hosts New Complimentary Webinar, “The Evolution of Payments: It’s More Than Just a Transaction”
10. DrugDev Webinars in December to Explore What Comes Next for ALS Research and How We Can Make Life Easier for Clinical Sites
11. SPIE Supports International Day of Light to Promote Awareness of Life-saving, Live-enhancing light
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... , ... October 11, 2017 , ... ComplianceOnline’s Medical Device ... on 7th and 8th June 2018 in San Francisco, CA. The Summit brings together ... as several distinguished CEOs, board directors and government officials from around the world to ...
(Date:10/11/2017)... ... October 11, 2017 , ... A new ... rates in frozen and fresh in vitro fertilization (IVF) transfer cycles. ... to IVF success. , After comparing the results from the fresh and frozen ...
(Date:10/10/2017)... California (PRWEB) , ... October 10, 2017 , ... Dr. ... speaking at his local San Diego Rotary Club. The event entitled ... Diego, CA and had 300+ attendees. Dr. Harman, DVM, MPVM was joined by ...
(Date:10/9/2017)... Oct. 9, 2017  BioTech Holdings announced today ... which its ProCell stem cell therapy prevents limb ... The Company, demonstrated that treatment with ProCell resulted ... saved as compared to standard bone marrow stem ... resulted in reduction of therapeutic effect.  ...
Breaking Biology Technology:
(Date:4/17/2017)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... 2016 Annual Report on Form 10-K on Thursday April 13, 2017 ... ... Investor Relations section of the Company,s website at http://www.nxt-id.com  under ... http://www.sec.gov . 2016 Year Highlights: ...
(Date:4/11/2017)... -- Research and Markets has announced the addition of ... offering. ... market to grow at a CAGR of 30.37% during the period ... has been prepared based on an in-depth market analysis with inputs ... growth prospects over the coming years. The report also includes a ...
(Date:4/5/2017)... April 5, 2017  The Allen Institute for Cell ... Explorer: a one-of-a-kind portal and dynamic digital window into ... data, the first application of deep learning to create ... cell lines and a growing suite of powerful tools. ... these and future publicly available resources created and shared ...
Breaking Biology News(10 mins):